Association of Fenofibrate Add-on Therapy with Postoperative Diabetic Retinal Outcomes After Cataract Surgery in Patients with Type 2 Diabetes Mellitus

Purpose: To examine whether preoperative fenofibrate-plus-statin exposure was associated with postoperative diabetic macular edema (DME)-related and proliferative diabetic retinopathy (PDR)-related composites compared with statin exposure alone. Methods: This retrospective cohort study used the TriNetX Global Collaborative Network. Adults with type 2 diabetes undergoing cataract surgery who received fenofibrate plus statin therapy were matched 1:1 with those receiving statin therapy alone. The co-primary outcomes were a DME-related composite, defined by a DME diagnosis or intravitreal injection, and a PDR-related composite comprising PDR, panretinal photocoagulation, or vitreous hemorrhage. Cox models estimated hazard ratios (HRs) over cumulative 1- to 5-year horizons. Sensitivity analyses evaluated 6-month outcomes, recent preoperative fenofibrate exposure, a laboratory-complete cohort, and Nd:YAG capsulotomy. Results: Matching yielded 2,521 pairs. After outcome-specific exclusions, the DME-related composite analysis included 2,292 exposed and 2,327 comparator patients. Fenofibrate-plus-statin exposure was associated with a lower hazard of the DME-related composite at every horizon, including 1 year (HR, 0.486 [95% confidence interval [CI], 0.324-0.728], P < 0.001) and 5 years (HR, 0.678 [95% CI, 0.515-0.892], P = 0.005). For the PDR-related composite, the 95% CI excluded 1.0 only at 2 years (HR, 0.605 [95% CI, 0.397-0.922], P = 0.018). Sensitivity analyses using a recent-exposure definition and a laboratory-complete cohort generally supported the DME-related composite finding, whereas Nd:YAG capsulotomy hazards were similar between groups. Conclusion: Preoperative fenofibrate-plus-statin exposure was associated with a lower hazard of the postoperative DME-related composite, while findings for the PDR-related composite were inconclusive. Prospective validation is needed

Authors

Institutions

Publication Details

Journal
Retina
Published
2026-11-09
DOI
https://doi.org/10.1097/iae.0000000000005050
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of Fenofibrate Add-on Therapy with Postoperative Diabetic Retinal Outcomes After Cataract Surgery in Patients with Type 2 Diabetes Mellitus

Sheng-Chu Chi, Min‐Huei Hsu, Hsin-Ho Chang, Yan-Jie Su
Retina
Retinal Diseases and Treatments
article

Association of Fenofibrate Add-on Therapy with Postoperative Diabetic Retinal Outcomes After Cataract Surgery in Patients with Type 2 Diabetes Mellitus

Sheng-Chu Chi, Min‐Huei Hsu, Hsin-Ho Chang, Yan-Jie Su
article en

Abstract

Purpose: To examine whether preoperative fenofibrate-plus-statin exposure was associated with postoperative diabetic macular edema (DME)-related and proliferative diabetic retinopathy (PDR)-related composites compared with statin exposure alone. Methods: This retrospective cohort study used the TriNetX Global Collaborative Network. Adults with type 2 diabetes undergoing cataract surgery who received fenofibrate plus statin therapy were matched 1:1 with those receiving statin therapy alone. The co-primary outcomes were a DME-related composite, defined by a DME diagnosis or intravitreal injection, and a PDR-related composite comprising PDR, panretinal photocoagulation, or vitreous hemorrhage. Cox models estimated hazard ratios (HRs) over cumulative 1- to 5-year horizons. Sensitivity analyses evaluated 6-month outcomes, recent preoperative fenofibrate exposure, a laboratory-complete cohort, and Nd:YAG capsulotomy. Results: Matching yielded 2,521 pairs. After outcome-specific exclusions, the DME-related composite analysis included 2,292 exposed and 2,327 comparator patients. Fenofibrate-plus-statin exposure was associated with a lower hazard of the DME-related composite at every horizon, including 1 year (HR, 0.486 [95% confidence interval [CI], 0.324-0.728], P < 0.001) and 5 years (HR, 0.678 [95% CI, 0.515-0.892], P = 0.005). For the PDR-related composite, the 95% CI excluded 1.0 only at 2 years (HR, 0.605 [95% CI, 0.397-0.922], P = 0.018). Sensitivity analyses using a recent-exposure definition and a laboratory-complete cohort generally supported the DME-related composite finding, whereas Nd:YAG capsulotomy hazards were similar between groups. Conclusion: Preoperative fenofibrate-plus-statin exposure was associated with a lower hazard of the postoperative DME-related composite, while findings for the PDR-related composite were inconclusive. Prospective validation is needed

Retina
National Yang Ming Chiao Tung University (TW), Taipei Veterans General Hospital (TW), Wan Fang Hospital (TW), Taipei Medical University (TW)
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon